Literature DB >> 25189251

TIMP2 gene polymorphisms are associated with hypertension in patients with myocardial infarction.

José Manuel Rodríguez-Pérez1, Nancy Martínez-Rodríguez, Gilberto Vargas-Alarcón, Maite Vallejo, Irma Eloisa Monroy-Muñoz, Carlos Posadas-Romero, Eric Kimura-Hayama, Teresa Juárez-Cedillo, José Manuel Fragoso, Nonanzit Pérez-Hernández.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25189251     DOI： 10.1007/s12041-014-0388-6

Source DB:  PubMed          Journal:  J Genet        ISSN： 0022-1333            Impact factor:   1.166


× No keyword cloud information.
  23 in total

1.  Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.

Authors:  S Hinan Ahmed; Leslie L Clark; Weems R Pennington; Carson S Webb; D Dirk Bonnema; Amy H Leonardi; Catherine D McClure; Francis G Spinale; Michael R Zile
Journal:  Circulation       Date:  2006-04-24       Impact factor: 29.690

2.  Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease.

Authors:  Benjamin D Horne; Nicola J Camp; John F Carlquist; Joseph B Muhlestein; Matthew J Kolek; Zachary P Nicholas; Jeffrey L Anderson
Journal:  Am Heart J       Date:  2007-10       Impact factor: 4.749

3.  Polymorphisms of MMP-3 and TIMP-4 genes affect angiographic coronary plaque progression in non-diabetic and type 2 diabetic patients.

Authors:  Qiu Jing Chen; Lin Lu; Wen Hui Peng; Jian Hu; Xiao Xiang Yan; Ling Jie Wang; Qi Zhang; Rui Yan Zhang; Wei Feng Shen
Journal:  Clin Chim Acta       Date:  2009-04-16       Impact factor: 3.786

Review 4.  Matrix metalloproteinases and cardiovascular disease.

Authors:  C M Dollery; J R McEwan; A M Henney
Journal:  Circ Res       Date:  1995-11       Impact factor: 17.367

5.  Structure and characterization of the human tissue inhibitor of metalloproteinases-2 gene.

Authors:  K Hammani; A Blakis; D Morsette; A M Bowcock; C Schmutte; P Henriet; Y A DeClerck
Journal:  J Biol Chem       Date:  1996-10-11       Impact factor: 5.157

Review 6.  Androgens and cardiovascular disease.

Authors:  Peter Y Liu; Alison K Death; David J Handelsman
Journal:  Endocr Rev       Date:  2003-06       Impact factor: 19.871

7.  Cloning of the human tissue inhibitor of metalloproteinase-4 gene (TIMP4) and localization of the TIMP4 and Timp4 genes to human chromosome 3p25 and mouse chromosome 6, respectively.

Authors:  T M Olson; S Hirohata; J Ye; K Leco; M F Seldin; S S Apte
Journal:  Genomics       Date:  1998-07-01       Impact factor: 5.736

8.  Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.

Authors:  Z S Galis; G K Sukhova; M W Lark; P Libby
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

9.  Tissue inhibitor of metalloproteinase 2 and coronary artery lesions in Kawasaki disease.

Authors:  Kenji Furuno; Hidetoshi Takada; Ken Yamamoto; Kazuyuki Ikeda; Takuro Ohno; Vahid Khajoee; Yumi Mizuno; Toshiro Hara
Journal:  J Pediatr       Date:  2007-06-15       Impact factor: 4.406

10.  Biomarkers of extracellular matrix metabolism (MMP-9 and TIMP-1) and risk of stroke, myocardial infarction, and cause-specific mortality: cohort study.

Authors:  Jonas Hansson; Ramachandran S Vasan; Johan Ärnlöv; Erik Ingelsson; Lars Lind; Anders Larsson; Karl Michaëlsson; Johan Sundström
Journal:  PLoS One       Date:  2011-01-19       Impact factor: 3.240
View more
  2 in total

1.  TIMP-2 SNPs rs7342880 and rs4789936 are linked to risk of knee osteoarthritis in the Chinese Han Population.

Authors:  Pengcheng Xu; Wen Guo; Tianbo Jin; Jihong Wang; Dongsheng Fan; Zengtao Hao; Shangfei Jing; ChaoQian Han; Jieli Du; Dong Jiang; Shuzheng Wen; Jianzhong Wang
Journal:  Oncotarget       Date:  2017-01-03

2.  Germline Variants in Angiogenesis-Related Genes Contribute to Clinical Outcome in Head and Neck Squamous Cell Carcinoma.

Authors:  Dorota Butkiewicz; Agnieszka Gdowicz-Kłosok; Małgorzata Krześniak; Tomasz Rutkowski; Barbara Łasut-Szyszka; Krzysztof Składowski
Journal:  Cancers (Basel)       Date:  2022-04-06       Impact factor: 6.639
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.